CVS-1123
CVS-1123 is an orally active direct thrombin inhibitor. CVS-1123 inhibits in vitro platelet aggregation of γ-thrombin and prolongs activated partial thromboplastin time. CVS-1123 alters the thrombotic response to deep vessel wall damage in arterial and venous circulation. CVS-1123 can be used in antithrombotic studies
Para uso exclusivo en investigación. No vendemos a pacientes.
- No. CAS: 151275-19-3
- Fòrmula: C24H42N6O6
- Peso molecular:510.63
-
Almacenamiento:
Please store the product under the recommended conditions in the Certificate of Analysis.
Actividad biológica
Descripciòn
Chemical Information
-
No. CAS 151275-19-3
-
Peso molecular 510.63
-
Fòrmula C24H42N6O6
-
SMILES
O=C([C@H](CC(OC)=O)NC(C(CCC)CCC)=O)N1[C@H](C(N[C@H](C=O)CCCNC(N)=N)=O)CCC1
-
Envío
Room temperature in continental US; may vary elsewhere.
-
Almacenamiento
Please store the product under the recommended conditions in the Certificate of Analysis.
Pureza y Documentación
Referencias
[1]. Rebello SS, et al. CVS-1123, a direct thrombin inhibitor, prevents occlusive arterial and venous thrombosis in a canine model of vascular injury. J Cardiovasc Pharmacol. 1997 Feb;29(2):240-9. [Content Brief]
[2]. Cousins GR, et al. Orally effective CVS-1123 prevents coronary artery thrombosis in the conscious dog. Circulation. 1996 Oct 1;94(7):1705-12. [Content Brief]
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)